CD8 T cell are key players in the fight against cancer. In order for CD8 T cells to kill tumor cells they need to enter into the tumor, migrate within the tumor microenvironment and respond adequately to tumor antigens. The recent development of improved imaging approaches, such as 2-photon microscopy, and the use of powerful mouse tumor models have shed light on some of the mechanisms that regulate anti-tumor T cell activities. Whereas such systems have provided valuable insights, they do not always predict human responses. In human, our knowledge in the field mainly comes from a description of fixed tumor samples from human patients, as well as in vitro studies. However, in vitro models lack the complex three-dimensional tumor milieu and, therefore, are incomplete approximations of in vivo T cell activities. Fresh slices made from explanted tissue represent a complex multi-cellular tumor environment that can act as an important link between co-cultured studies and animal models. Originally set up in murine lymph nodes 1 and previously described in a JoVE article 2
Introduction
CD8 T cells play a key role in the battle against cancer. However, many suppressive mechanisms prevent T lymphocytes from killing malignant cells. Over the last years, several promising strategies that release the brakes on T cells have been developed and used in the clinic 5 . The two approaches that retain considerable attention are immune checkpoint-targeting antibodies, such as anti-PD-1 and adoptive T cell therapies. Nevertheless, despite recent successes, only a subset of patients benefit from these therapies 6 . A major challenge is to identify mechanisms of resistance to cancer immunotherapy in order to develop more efficient treatments. Another challenge is to develop model systems in which novel therapies can be characterized and tested for their potency and safety. So far, most of these assays are based on in vitro cell culture systems that poorly mimic the complexity of the tumor tissue.
Ex vivo tissue slices is a promising technique, as it preserves the original tissue microenvironment 7 . Over the years, we have set up this approach to track the dynamics of T lymphocytes in various tissues. Our results indicate that fluorescently labeled T cells added atop murine lymph node slices migrate into the tissue and respond to their appropriate microenvironmental cues 1, 2 . Similarly, T lymphocytes overlaid onto human lung tumor slices are rapidly recruited into the tumor stroma 3 . Using this technique, we have identified the extracellular matrix as an important element in controlling the distribution and migration of T cells within human tumors 3, 4 . Because the behavior of ex vivo purified and plated T cells does not necessarily reflect the behavior of resident intratumoral T lymphocytes, we have recently refined this approach 
Agarose embedding and vibratome slicing of human lung tumors
NOTE: Perform all steps until 2.10 under sterile conditions.
1. Prepare 5% agarose solution for embedding by dissolving 1 g low-melting point agarose in 20 mL sterile of Phosphate-buffered saline (PBS) without calcium and magnesium. Microwave this solution until the agarose is completely dissolved. Allow the agarose to cool at 37 °C by placing the solution in an incubator at 37 °C for 5 min. 2. In a tissue culture hood, prepare complete RPMI-1640 medium (without phenol red) containing 10% fetal bovine serum (FBS), 4 mM L glutamine and 1x penicillin and streptomycin. 3. Add 1.1 mL complete RPMI-1640 medium per well to a 6-well cell culture plate and place a 30 mm cell culture insert in each well. Set the plate aside in an incubator at 37 °C for 30 min until step 2.12. 4. Place sterilized stainless steel flat washers (inner diameter of 5 mm, outside diameter of 10 mm and thickness of 1 mm) in a 35-mm plastic dish filled with RPMI complete medium. Washers will be further used to concentrate the antibodies on the vibratome-cut slice. 5. Place the tumor biopsy in a 10-cm plastic dish and cut the tumor with a sharp blade into small cube shape fragments of approximately 5x5 mm length. 6. Take out the agarose from the incubator and pour the solution into a 35-mm plastic dish. 7. Use a pair of forceps to carefully transfer the tumor fragments to a tissue wipe to remove the excess of medium. Insert the fragments into the agarose and position them at the bottom of the plastic dish. Leave the agarose gel on ice for 5 min to solidify. 8. Once the agarose solidifies, invert the plastic dish and use a spatula to release the entire gel. 9. Use a sharp blade to trim the excess agarose surrounding the tumor fragment, leaving 3-5 mm of gel around the tissue. 10. Mount each agarose block on the specimen disk of the vibratome with a drop of non-toxic butyl cyanoacrylate tissue glue. Fill the vibratome buffer tray with sterile ice-cold PBS and Install the specimen disk in the tray. 11. Cut the agarose embedded tissue into 350 µm thick slices. Adjust the vibratome settings at a slow range speed (0.2-0.3 mm/s) and the vibration frequency at a medium range (1.5 mm). 12. Using fine forceps, carefully collect the tumors slices as they are being cut and place them flat onto the cell culture inserts of a 6-well plate (step 2.3). Transfer 1 slice on each insert. Use great care when handling slices as they can be easily damaged. 13. Use fine forceps to place stainless steel washers on each individual slice. Make sure washers are well positioned on the agarose surrounding the tumor tissue. 14. Maintain the culture plate at 37 °C in a 5% CO 2 humidified incubator for 10 min. Proceed to immunostaining.
Immunostaining of resident CD8 T cells and tumor cells
1. Dilute the antibodies (final concentration 10 µg/mL) and the nuclear dye (final concentration 1 µg/mL) in RPMI-1640 media without phenol red. NOTE: Use fluorescently-coupled anti-CD8 (murine IgG, clone SK1) and anti-EpCAM (epithelial cell adhesion molecule) (murine IgG HEA-125) antibodies to label CD8 T lymphocytes and tumor epithelial cells, respectively. Use fluorescently-coupled anti-CD90/Thy1 (murine IgG, clone 5E10) antibody to label fibroblasts and activated endothelial cells. Use 4',6-diamidino-2-phenylindole (DAPI) to label the nucleus of cells with a compromised plasma membrane in order to assess tissue viability. 2. Remove the culture plates from the incubator and use a pipette to aspirate any liquid inside the stainless steel washers. Do not remove the 1.1 mL RPMI-1640 media placed under the cell culture inserts (step 2.3). 3. Without touching the slice and using a pipette tip, add 40 µL of the solution containing the antibodies onto each tumor slice. 4. Incubate the plate at 37 °C for 15 min to allow antibody staining. 5. With fine forceps, remove the washers, take out the slices, and dip them 10 s in RPMI-1640 media without phenol red. Place back the slices onto the cell culture inserts and add a drop of phenol red-free RPMI-1640 medium on each individual slice. Maintain the plate at 37 °C for 10 min. Proceed to imaging.
Imaging and analyzing resident CD8 T cell migration within human lung tumor slices
NOTE: The confocal microscope used in this protocol is an upright spinning disk equipped with a 25x water immersion objective (25x/0.95 N.A.).
2. Set up a system to constantly perfuse tumor slices with oxygenated (5% CO 2 , 95% O 2 ) phenol red-free RPMI medium (Figure 1) . Use a peristaltic pump to flow the perfusion media into the imaging chamber and to aspirate the solution to a waste collection flask. 3. Run the peristaltic pump to allow the oxygenated solution to go through the perfusion tubes.
2. With fine forceps, take out the slice from the 6-well plate and transfer it to the 35-mm plastic dish filled with phenol red-free RPMI medium.
Immobilize the slice with a 19.7 mm diameter slice anchor with 2 mm spaced-threads. Place the Petri dish on the imaging stage of the microscope. Connect the inlet and outlet tips of the perfusion system. Turn on the perfusion system and set the media flow rate to 0. 
Representative Results
Human lung tumors are usually highly infiltrated in CD8 T cells that are preferentially found in the stroma 3, 4 . By following this protocol one should expect to visualize a large number of immunostained CD8 T in human lung tumor slices. A co-labeling with anti-EpCAM and anti-CD90 antibodies should permit to delineate tumor islets and stromal areas. Fibrillar collagen, abundant in the tumor stroma, can be visualized without exogenous staining by using second harmonic generation on a two-photon microscope 3, 4 . Note that some human lung tumors present no clear distinction between tumor islets and stroma. Such tumors should be discarded as well as specimen presenting large areas of cell necrosis identified by non-specific binding of antibodies and DAPI staining. Consistent with published results obtained in human lung and ovarian carcinomas, resident CD8 T cells are more concentrated in the stroma compared to tumor islets 4 . A representative example of CD8 T cell distribution in relation to tumor cells and CD90 is shown in Figure 2 .
The slice assay allows for the analysis of resident T cell motility in different tumor regions. Useful criteria for comparing CD8 T cell motility in different regions include the average velocity (path length divided by the time duration sampled) and the displacement length (the vector between the beginning and end of a track). Although scarce in tumor islets, CD8 T cells migrate more actively in this compartment compared to the stroma (Figure 3) . On average, the mean velocity of individual CD8 T cells should be close to 4 µm/min in the tumor stroma with high intra and inter-tumor variabilities 4 . In the tumor stroma, the motility of resident T cells is strongly influenced by the density and orientation of extracellular matrix fibers 3, 4 . A successful experiment will result in less T cells present in dense matrix areas compared to loose matrix regions, consistent with published results 3, 4 .
Note that some human lung tumors exhibit a very high level of autofluorescence precluding imaging of resident T cells. Such feature is rapidly observed at the beginning of the imaging session. Autofluorescent tumors should be discarded. A representative example of resident CD8 T cells in an autofluorescent tumor is shown in Figure 4 .
Discussion
A straightforward, quick, and robust technique for generating human lung tumor slices and assessment of the dynamic behavior of resident CD8 T cells in a preserved tumor environment using a confocal microscope is described. This protocol is a refinement of a previous JoVE article that describes the monitoring of plated T cells onto murine lymph node slices 2 .
Bleaching of fluorescent dyes must be considered especially with first generation dyes like fluorescein isothiocyanate and phycoerythrin. We found that a pronounced photobleaching of directly-coupled antibodies occurred with a two-photon microscope. Conversely, minimal photobleaching was noticed with confocal microscopes, especially using bright fluorescent dyes developed recently.
Antibodies are relatively big molecules and therefore their penetration into the tissue can be difficult. This step can be improved by increasing the incubation time. In addition, the use a smaller staining reagents such as directly-coupled Fab fragments of antibodies represents a good alternative.
All antibodies described in this protocol have been previously validated and known to produce bright staining 4 . Therefore, isotype controls are not required. However, if modifications to this method using other antibodies are desired, then the use of isotype control antibodies is highly recommended.
This experimental system presents some limitations. The cutting procedure will damage the tissue, which may affect the behavior of CD8 T cells, especially near the cut surface. In addition, a number of soluble factors (e.g. chemokines) instrumental in controlling the migration of T cells can be lost. One way to bypass these problems is by monitoring T cells located at several tens of microns from the surface in presumably healthier regions of the tissue. Published experiments reveal that T cells localized deep within the tissue migrate more actively than T cells localized near the cut surface 4 . We have used confocal microscopes for our studies but it is likely that two-photon microscopes will increase the spatial resolution in depth.
This approach relies on the use of fluorescently-coupled antibodies that are not neutral molecules. Full-sized antibodies are susceptible to affect the normal functioning of T cells in different ways. First, anti-CD8 antibodies can alter T cell migration by triggering an intracellular signaling cascade capable of affecting the cytoskeleton of the lymphocyte. Second, anti-CD8 antibodies can modulate the interaction between CD8 and MHC class I molecules, an important step in the antigen recognition process. Third, intact antibodies can bind to Fc receptors expressed by many myeloid cells distributed in the tumor and therefore susceptible to increase the non-specific signal. We have no indication that such a problem affected our data, probably because Fc receptors of resident myeloid cells are, unlike cells in culture, saturated with immunoglobulins present within the tumor milieu. Indeed, the addition of serum during the labeling procedure, a process known to block free Fc receptors, did not change the immuno-staining. Nonetheless, Fab fragments of antibodies, devoid of Fc region, as well as antibodies mutated in their Fc region and camelid-derived antibody fragments 8 represent other alternative strategies to track resident cells with fluorescent tracers.
Over the last decades, several model systems have been developed and used for the real-time imaging of T lymphocytes. These include in vitro preparations of T cells previously purified and cultured with antigen-presenting cells. Such preparations have allowed remarkable progress in defining the mechanisms of antigen recognition and responsiveness. However, they lack the complexity of the tissue environment. Other preparations have been established that more closely mimic the structure of a native tissue. For examples, three-dimensional collagen gel matrices in which purified T cells have been embedded, as well as culture of reaggregated tissue fragments have been used to monitor the dynamic behavior of T lymphocytes with fluorescent imaging technologies 9 . These systems present the advantage of an architecture close to the native tissue, but they lack other important cellular and soluble factors. In mouse, two-photon intravital microscopy has been employed to track T cells in the truly physiological environment of an intact organ 10 . However, such approach is technically difficult to set up. In addition, mouse models show notable differences with the human physiology.
The technique described in this protocol represents a complex multi-cellular tumor environment that is uniquely positioned to act as an important link between co-culture studies and animal models.
The protocol described herein can also be used for tracking the motility of other cells than CD8 T lymphocytes for which antibodies have been generated. Furthermore, the technique can be adapted to other human and murine tumors and tissues. For instance, we have been able to image in real time the dynamics of B cells labeled with an anti-CD19 antibody in fresh human tonsils.
The technique described in this protocol allows to screen for therapeutic molecules controlling T cell motility in tissues. The accessibility of the culture system permits to apply some pharmacological reagents and test their consequences on T cell migration. It is now accepted that in growing tumors, CD8 T cells exhibit a low migration and reduced contacts with tumor cells 11 . Importantly, the scarce presence of T cells in tumor cell regions is associated with a bad outcome and is considered to be one of the resistance mechanisms to T cell-based cancer immunotherapy. Multiple obstacles limiting T cells from migrating in tumors have been identified including a dense extracellular matrix. In this respect, the identification of molecules able to restore T cell motility and interaction with malignant cells represents an important step in cancer immunotherapy. In a previous study, we found that a partial degradation of collagen with collagenase, acutely applied to human lung slices, improves the contact of T cells with tumor cells.
Finally, the possibility to keep human tumor slices in culture for up to several days 7, 12, 13 offers a number of promising applications in term of T cells and immunotherapy. However, the stability of the model system during long term culture is an important parameter that needs to be thoroughly assessed.
